AUPH - Aurinia Pharmaceuticals Projected Sales Volume

Aurinia Pharmaceuticals Inc - graphic logo of issuer AUPH

Aurinia Pharmaceuticals (AUPH) is developing therapies for renal pathologies, which impacts its financial profile. The company's expected sales volume is available on the GURU.Markets chart, where the 0.16 mark serves as the current indicator. Optimization is possible through expansion into Asian and European markets, although investor distrust of management and a deficit of merger deals act as constraints.

AUPH - auriniapharma.com Projected Sales Volume over the range 07/04/2022 - 11/18/2026

Financial and market metric breakdowns for Aurinia Pharma (AUPH)

- stock value and consensus price forecast:
Basic company analysis:AUPH Aurinia Pharma
Signature product of Aurinia Pharmaceuticals Inc

The commercial success of Aurinia Pharmaceuticals (AUPH) drugs and the synergy between researchers and the sales department directly drive staff motivation through a bonus system. By analyzing the company's sales history and forecasts, an investor can discern market revenue expectations, where real-time price action reflects the quality of asset management, and the steady growth of this indicator confirms the fundamental stability of the current market price.

Who Aurinia Pharmaceuticals competes with

Company Projected Revenue Argenx (ARGX)|BioNTech - Company Revenue Forecast|Projected Sales Volume ABVX (Abivax)|ADMA Bio (ADMA) - Company Expected Sales Volume|PTGX - Company Projected Revenue|Company Future Sales immunovant.com IMVT|KNSA: Projected Sales Volume|Grifols - Company Future Revenue|ADPT (Adaptive Biotech) - Projected Sales Volume|Company Projected Revenue CLDX|Projected Sales Volume BCRX|Projected Sales Volume Vera Therapeutics (VERA)|Dianthus Therapeutics - Company Future Sales Volume|Pharvaris - Company Projected Revenue|ABCL - Company Projected Revenue|TRML - Projected Sales Volume|PGEN: Projected Sales Volume|Company Revenue Forecast PHAR|Company Future Sales Volume NKTR|UPB: Company Future Revenue|Company Projected Revenue zenasbio.com (ZBIO)|IMNM (Immunome Corp) - Company Future Revenue|Projected Sales Volume GOSS (Gossamer Bio, Inc.)|KALV (KalVista Pharmaceuticals) - Company Expected Revenue|SEPN - Company Projected Revenue|Company Future Revenue PVLA (Pieris Pharma)|Savara Pharma (SVRA) - Company Projected Revenue|Rigel Pharmaceuticals Inc (RIGL) - Projected Sales Volume|Company Projected Revenue AnaptysBio|Astria Therapeutics - Company Expected Revenue|Projected Sales Volume ENGN|Company Projected Revenue Volume RAPT|Company Projected Revenue Aerovate Therapeutics, Inc. JBIO|Aclaris Therapeutics (ACRS) - Company Expected Sales Volume|KYTX: Company Future Sales Volume|Company Future Sales Tiziana Life Sciences TLSA|CABA: Projected Sales Volume|Company Expected Sales Volume Ventyx Biosciences Inc. (VTYX)|Company Future Sales Volume THTX|Avalo Therapeutics, Inc (AVTX) - Company Future Sales|Projected Sales Volume ELDN|Company Future Sales Volume agenusbio.com AGEN|Projected Sales Volume CLYM (climbbio.com)|Projected Sales Volume Zura Bio Ltd ZURA|ATYR - Company Projected Revenue|Adagene Inc (ADAG) - Company Future Sales Volume|IMA: Projected Sales Volume|Shattuck Therapeutics (STTK) - Projected Sales Volume|Company Projected Revenue equilliumbio.com|CNTB: Company Future Revenue|Projected Sales Volume IMUX|ATRA (Atara Bio) - Company Future Revenue|Company Projected Revenue InflaRx N.V. IFRX|x4pharma.com - Company Projected Revenue|ACET - Company Projected Revenue|Company Future Revenue CELU (celularity.com)|INMB: Projected Sales Volume|Barinthus Biotherapeutics Corp - Company Future Revenue|Company Future Sales Volume KZR|Company Future Sales Volume SAB Biotherapeutics (SABS)|Company Future Sales Volume AKTX (Akari Therapeutics Plc)|Company Future Sales Volume Enlivex Therapeutics Ltd. ENLV|Q32 Bio Corp - Company Future Sales Volume|GOVX - Company Future Sales Volume|EDSA - Company Projected Revenue|Company Future Revenue IBIO (iBio, Inc.)|CARM: Projected Sales Volume|XTL Biopharmaceuticals, Ltd. (XTLB) - Projected Sales Volume|Company Projected Revenue boltbio.com|Projected Sales Volume hcwbiologics.com|Company Future Sales Volume APVO (aptevotherapeutics.com)|Company Future Sales AIM ImmunoTech, Inc.|Projected Sales Volume ADTX (Aditxt)|Company Future Revenue GRI|XRTX - Company Projected Revenue|HIND: Company Projected Revenue|REVB (Revelation Biosciences Corp) - Company Future Sales Volume|Company Revenue Forecast INDP|Company Projected Revenue Scinai Immunotherapeutics Ltd|calcimedica.com (CALI) - Company Future Sales|Company Projected Revenue Affimed NV (AFMD)|Allakos - Company Revenue Forecast|Company Projected Revenue HOOKIPA Pharma, Inc. HOOK|IGMS - Company Future Sales Volume|ITOS: Company Future Sales Volume|Company Expected Sales Volume Ocean Biomedical|TCBP: Projected Sales Volume|Third Harmonic Bio, Inc - Company Future Revenue